Versant Ventures IV, LLC
Insider CIK 1456589 · OPHT 10% owner · CLVS 10% owner · NARI 10% owner · TPST 10% owner · BOLD 10% owner · CRSP 10% owner · OYST 10% owner · CTNM 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TPST Tempest Therapeutics, Inc. | S Sale | 2024-08-12 | 2024-08-12 | 387,999 | $1.10 | $426.8K | 209,941 | SEC↗ |
| TPST Tempest Therapeutics, Inc. | S Sale | 2024-08-08 | 2024-08-12 | 400,000 | $1.35 | $540.0K | 597,940 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 455 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 70,498 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 298,975 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 1,931 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 275,769 | — | $0 | 710,494 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 689 | — | $0 | 12,123 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 110,187 | — | $0 | 1,934,776 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 317,988 | — | $0 | 1,741,107 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 434,725 | — | $0 | 434,725 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 2,182 | — | $0 | 11,434 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 348,143 | — | $0 | 1,824,589 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 1,423,119 | — | $0 | 1,423,119 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 9,252 | — | $0 | 9,252 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 1,476,446 | — | $0 | 1,476,446 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 57,565 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 145 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 22,312 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion deriv | 2024-04-09 | 2024-04-11 | 90,747 | — | $0 | 0 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion | 2024-04-09 | 2024-04-11 | 2,531 | — | $0 | 2,531 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion | 2024-04-09 | 2024-04-11 | 148,312 | — | $0 | 148,312 | SEC↗ |
| CTNM Contineum Therapeutics, In | C Conversion | 2024-04-09 | 2024-04-11 | 391,785 | — | $0 | 391,785 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 1,003,658 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 2,236,888 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 414,607 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | U Tender | 2023-01-03 | 2023-01-04 | 2,465 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 1,261 | — | $0 | 2,465 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 200,213 | — | $0 | 414,607 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 51,556 | — | $0 | 51,556 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2022-01-05 | 2022-01-07 | 51,556 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 51,556 | — | $0 | 51,556 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 1,261 | — | $0 | 3,726 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 51,556 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-12-21 | 2021-12-23 | 200,213 | — | $0 | 614,820 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 1,912 | $14.63 | $28.0K | 6,518 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 242,943 | $15.09 | $3.67M | 815,033 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 1,531 | $15.09 | $23.1K | 4,987 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | S Sale | 2021-10-18 | 2021-10-20 | 303,614 | $14.63 | $4.44M | 1,057,976 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 320,340 | — | $0 | 1,361,590 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 82,486 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 2,018 | — | $0 | 8,430 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-05-12 | 2021-05-14 | 82,486 | — | $0 | 82,486 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 1,990 | — | $0 | 10,448 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 82,491 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 82,491 | — | $0 | 82,491 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-03-26 | 2021-03-30 | 320,368 | — | $0 | 1,681,930 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 5,607 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 325,000 | — | $0 | 2,236,888 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 6,500 | — | $0 | 6,500 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 6,500 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | J Other | 2021-02-17 | 2021-02-19 | 5,607 | — | $0 | 5,607 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 164,825 | — | $0 | 164,825 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 3,004,415 | — | $0 | 2,705,162 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 164,825 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | J Other | 2020-11-17 | 2020-11-19 | 18,925 | — | $0 | 17,040 | SEC↗ |
| ISEE IVERIC bio, Inc. | J Other | 2020-06-19 | 2020-06-23 | 3,428,221 | — | $0 | 1,714,111 | SEC↗ |
| ISEE IVERIC bio, Inc. | J Other | 2020-06-19 | 2020-06-23 | 34,282 | — | $0 | 34,282 | SEC↗ |
| ISEE IVERIC bio, Inc. | J Other | 2020-06-19 | 2020-06-23 | 34,282 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | J Other | 2020-06-19 | 2020-06-23 | 21,597 | — | $0 | 10,798 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 3,571,426 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 1,197,058 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion deriv | 2020-05-27 | 2020-05-27 | 977,058 | — | $0 | 0 | SEC↗ |
| NARI Inari Medical, Inc. | C Conversion | 2020-05-27 | 2020-05-27 | 5,745,542 | — | $0 | 5,745,542 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 1,941,500 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 566,158 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 10,420 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 495,388 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion deriv | 2019-11-04 | 2019-11-04 | 1,654,359 | — | $0 | 0 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | P Buy | 2019-11-04 | 2019-11-04 | 125,000 | $16.00 | $2.00M | 2,561,888 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 495,388 | — | $0 | 2,436,888 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 1,941,500 | — | $0 | 1,941,500 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | P Buy | 2019-11-04 | 2019-11-04 | 27,500 | $16.00 | $440.0K | 2,002,298 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 1,654,359 | — | $0 | 1,974,798 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 10,420 | — | $0 | 12,438 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | P Buy | 2019-11-04 | 2019-11-04 | 437,500 | $16.00 | $7.00M | 1,003,658 | SEC↗ |
| OYST Oyster Point Pharma, Inc. | C Conversion | 2019-11-04 | 2019-11-04 | 566,158 | — | $0 | 566,158 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2019-01-14 | 2019-01-16 | 129,709 | $2.30 | $298.3K | 5,142,333 | SEC↗ |
| OPHT Ophthotech Corp. | J Other | 2019-01-14 | 2019-01-16 | 817 | $2.30 | $1.9K | 32,394 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-04-23 | 2018-04-24 | 89,628 | $50.66 | $4.54M | 1,539,576 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-04-23 | 2018-04-24 | 2,630 | $51.00 | $134.1K | 45,171 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-04-23 | 2018-04-24 | 2,915 | $51.00 | $148.7K | 50,072 | SEC↗ |
| CRSP CRISPR Therapeutics AG | S Sale | 2018-04-23 | 2018-04-24 | 6,821 | $50.66 | $345.6K | 117,173 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2018-04-20 | 2018-04-24 | 2,947 | — | $0 | 13,277 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2018-04-20 | 2018-04-24 | 92,918 | — | $0 | 92,918 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2018-04-20 | 2018-04-24 | 92,918 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2018-04-20 | 2018-04-24 | 497,053 | — | $0 | 2,238,979 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 1,368,013 | — | $0 | 2,736,032 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 26,491 | — | $0 | 52,987 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 61,993 | — | $0 | 123,994 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 23,899 | — | $0 | 47,801 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 814,599 | — | $0 | 1,629,204 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 8,110 | — | $0 | 16,224 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 292,529 | — | $0 | 292,529 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 1,240 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 1,240 | — | $0 | 1,240 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 17,283 | — | $0 | 0 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 17,283 | — | $0 | 17,283 | SEC↗ |
| CRSP CRISPR Therapeutics AG | J Other | 2017-09-05 | 2017-09-07 | 292,529 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 3,029 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 1,249 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 1,081,477 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 480,856 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 198,410 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion deriv | 2016-07-25 | 2016-07-25 | 6,811 | — | $0 | 0 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 480,856 | — | $0 | 1,562,333 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 1,081,477 | — | $0 | 1,081,477 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 6,811 | — | $0 | 6,811 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 3,029 | — | $0 | 9,840 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 1,249 | — | $0 | 11,089 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | P Buy | 2016-07-25 | 2016-07-25 | 34,781 | $15.00 | $521.7K | 1,795,524 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | P Buy | 2016-07-25 | 2016-07-25 | 219 | $15.00 | $3.3K | 11,308 | SEC↗ |
| BOLD Audentes Therapeutics, Inc | C Conversion | 2016-07-25 | 2016-07-25 | 198,410 | — | $0 | 1,760,743 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2013-06-03 | 2013-06-05 | 3,400 | — | $0 | 10,200 | SEC↗ |
| CLVS Clovis Oncology, Inc. | J Other | 2013-06-03 | 2013-06-05 | 539,822 | — | $0 | 1,619,467 | SEC↗ |